Environmental Fate & Hazard Assessment Synthesis
Synthesize environmental toxicology data into regulatory risk assessments
What You Can Do
You can rapidly organize disparate environmental toxicology datasets—aquatic toxicity, terrestrial toxicity, persistence, bioaccumulation, metabolism—into coherent hazard profiles by environmental compartment. Claude synthesizes conflicting study results into defensible weight-of-evidence conclusions and drafts regulatory-compliant risk characterization language suitable for EPA, FDA, and ECHA dossiers, significantly accelerating the preparation of Ecological Risk Assessments and Environmental Assessment sections for pharmaceutical submissions.
Features
structures aquatic, terrestrial, and atmospheric hazard data into logical environmental assessment sections
flags missing studies, low-reliability data, and critical uncertainties early in the assessment process
reconciles conflicting acute/chronic toxicity results into defensible conclusions with transparent reasoning
generates EPA/FDA/ECHA-compliant risk characterization text ready for Environmental Assessment or dossier submission
maps environmental classifications (aquatic toxicity categories, persistence) to monitoring and mitigation requirements
applies standardized criteria to evaluate reliability and relevance of included toxicology studies
organizes multiple compounds or formulations side-by-side for relative risk ranking
refines and strengthens conclusions based on new data or regulatory feedback
Example Output
Example 1: Aquatic Hazard Summary
Compartment: Aquatic (Freshwater)
Acute Toxicity: Acute aquatic toxicity category 1 (LC₅₀ = 0.8 mg/L, Daphnia; 96-h OECD 202). Study reliability: 2 (guideline, GLP).
Chronic Toxicity: NOEC = 0.045 mg/L (Daphnia reproduction, 21-d OECD 211). Classification: Chronic aquatic toxicity category 1.
Weight-of-Evidence Conclusion: The compound presents a high chronic hazard in freshwater ecosystems. Aquatic classification: Acute 1, Chronic 1. Monitoring recommended for surface waters in manufacturing/disposal zones.
Example 2: Conflicting Data Synthesis
Bioaccumulation Finding: Three studies report log Kow 4.2–4.8 (borderline bioaccumulative per REACH criteria). Two terrestrial field studies show limited tissue accumulation (BCF <100). Reliability assessment: One high-quality in vitro study (Reliability 2); two field studies with moderate confounding (Reliability 3).
Weight-of-Evidence: Despite elevated log Kow, bioaccumulation potential is low-to-moderate. Recommend B classification (bioaccumulative) with lower monitoring priority than persistent compounds.
What's Included
- SKILL.md instruction file with prompting strategies for data organization and regulatory narrative drafting:
- Environmental Compartment Template: pre-structured sections for aquatic, terrestrial, and atmospheric hazard assessment
- Weight-of-Evidence Framework: systematic approach to resolving conflicting study results with transparency scoring
- Study Reliability Assessment Checklist: OECD/EPA criteria for evaluating toxicology study quality
- Regulatory Language Library: starter phrases and conclusions compliant with EPA, FDA, and ECHA guidance
Who It's For
- Environmental Toxicologists — synthesizing hazard data into risk assessments for pharmaceutical submissions
- Regulatory Affairs Specialists — organizing environmental assessment sections for FDA/EPA/EMA dossiers
- Drug Development Project Managers — accelerating environmental risk characterization during preclinical phases
- EHS/Compliance Managers — preparing Ecological Risk Assessments and environmental monitoring plans
- Environmental Scientists in Pharma — consolidating multi-study datasets into defensible conclusions
Best For
- Synthesizing 10+ conflicting acute/chronic toxicity studies into single weight-of-evidence conclusions
- Organizing environmental fate data (persistence, bioaccumulation, metabolism) by compartment
- Drafting Ecological Risk Assessment narratives for FDA/EPA/EMA environmental submissions
- Flagging data gaps and reliability issues in environmental toxicology datasets
- Creating regulatory-compliant hazard classification and risk characterization language
You might also like
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
You can submit raw mass spectrometry observations, instrument parameters, or sample preparation details to Claude and receive targeted diagnostic frameworks that explain anomalous results. Claude systematically generates plausible mechanistic explanations for unexpected protein abundance patterns, quantification inconsistencies, and PTM findings—then helps you design minimal, hypothesis-driven troubleshooting experiments to test them.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
Get comprehensive PCB design analysis covering power delivery networks, signal integrity, thermal management, and manufacturing constraints. Claude identifies potential issues early and provides specific, actionable optimization recommendations to reduce cost, improve reliability, and accelerate time-to-market. Suitable for designs from initial concept through production-ready layouts.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w